Literature DB >> 30032275

Proteinuria reaffirmed as a risk modifier in diabetic chronic kidney disease.

Gary C W Chan1, Sydney C W Tang1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30032275     DOI： 10.1093/ndt/gfy208

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  2 in total

1.  Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial.

Authors:  Kam Wa Chan; Alfred Siu Kei Kwong; Pun Nang Tsui; Simon Chi Yuen Cheung; Gary Chi Wang Chan; Wing Fai Choi; Wai Han Yiu; Yanbo Zhang; Michelle Man-Ying Wong; Zhang-Jin Zhang; Kathryn Choon Beng Tan; Lixing Lao; Sydney Chi Wai Tang
Journal:  BMJ Open       Date:  2021-01-12       Impact factor: 2.692

2.  Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis.

Authors:  Kam Wa Chan; Kam Yan Yu; Wai Han Yiu; Rui Xue; Sarah Wing-Yan Lok; Hongyu Li; Yixin Zou; Jinyuan Ma; Kar Neng Lai; Sydney Chi-Wai Tang
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.